Application of nanomaterials in diagnosis and treatment of glioblastoma

Application of nanomaterials in diagnosis and treatment of glioblastoma

Diagnosing and treating glioblastoma patients is currently hindered by several obstacles, such as tumor heterogeneity, the blood-brain barrier, tumor complexity, drug efflux pumps, and tumor immune escape mechanisms. Combining multiple methods can increase benefits against these challenges. For exam...

Full description

Bibliographic Details
Main Authors:	Shuangqi Yu, Lijie Chen, Hongyu Xu, Shengrong Long, Jiazhi Jiang, Wei Wei, Xing Niu, Xiang Li
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-12-01
Series:	Frontiers in Chemistry
Subjects:	glioblastoma glioma tumor targeting nanomaterial blood-brain barrier
Online Access:	https://www.frontiersin.org/articles/10.3389/fchem.2022.1063152/full

Similar Items

Potential Role of Carbon Nanomaterials in the Treatment of Malignant Brain Gliomas
by: Maria Caffo, et al.
Published: (2023-04-01)

Functionalized nanoparticles crossing the brain–blood barrier to target glioma cells
by: Yongyan Wu, et al.
Published: (2023-07-01)

Construction of nanomaterials as contrast agents or probes for glioma imaging
by: Wei Zhao, et al.
Published: (2021-05-01)

Advances in Nanotechnology-Based Immunotherapy for Glioblastoma
by: Lin Tang, et al.
Published: (2022-05-01)

Novel tumor necrosis factor-related long non-coding RNAs signature for risk stratification and prognosis in glioblastoma
by: Shengrong Long, et al.
Published: (2023-04-01)

The role of RNA modification in the generation of acquired drug resistance in glioma
by: Yu Yan, et al.
Published: (2022-11-01)

Tyrosine Kinase Inhibitors for Glioblastoma Multiforme: Challenges and Opportunities for Drug Delivery
by: Harpinder K. Brar, et al.
Published: (2022-12-01)

Blood–Brain Barrier Modulation to Improve Glioma Drug Delivery
by: Huilong Luo, et al.
Published: (2020-11-01)

Insights into the regulatory role of RNA methylation modifications in glioma
by: Shengrong Long, et al.
Published: (2023-11-01)

Synchronous Disintegration of Ferroptosis Defense Axis via Engineered Exosome‐Conjugated Magnetic Nanoparticles for Glioblastoma Therapy
by: Boyan Li, et al.
Published: (2022-06-01)

Evaluation of Zonulin Expression and Its Potential Clinical Significance in Glioblastoma
by: Roberta Repossi, et al.
Published: (2024-01-01)

Applications of Focused Ultrasound for the Treatment of Glioblastoma: A New Frontier
by: Andrew M. Hersh, et al.
Published: (2022-10-01)

The role of the gut microbiome and its metabolites in cerebrovascular diseases
by: Hongyu Xu, et al.
Published: (2023-04-01)

Development of targeted therapies in treatment of glioblastoma
by: Yuan-Yuan Xu, et al.
Published: (2015-09-01)

Development of Polymer-Based Nanoformulations for Glioblastoma Brain Cancer Therapy and Diagnosis: An Update
by: Bijuli Rabha, et al.
Published: (2021-11-01)

Recurrent Glioblastoma: Where we stand
by: Sanjoy Roy, et al.
Published: (2015-01-01)

Antibody Drug Conjugates in Glioblastoma – Is There a Future for Them?
by: Sagun Parakh, et al.
Published: (2021-12-01)

Nanomaterials for Diagnosis and Treatment of Brain Cancer: Recent Updates
by: Mahwash Mukhtar, et al.
Published: (2020-11-01)

The functional curcumin liposomes induce apoptosis in C6 glioblastoma cells and C6 glioblastoma stem cells in vitro and in animals
by: Wang YH, et al.
Published: (2017-02-01)

Brain co‐delivery of first‐line chemotherapy drug and epigenetic bromodomain inhibitor for multidimensional enhanced synergistic glioblastoma therapy
by: Yanjie Liu, et al.
Published: (2022-08-01)

Tectal glioblastoma Glioblastoma tetal
by: Feres Chaddad Neto, et al.
Published: (2007-12-01)

Regorafenib in Recurrent Glioblastoma Patients: A Large and Monocentric Real-Life Study
by: Giuseppe Lombardi, et al.
Published: (2021-09-01)

Transferrin-Targeted Liposomes in Glioblastoma Therapy: A Review
by: Paul Kawak, et al.
Published: (2023-08-01)

Development of bioactive materials for glioblastoma therapy
by: Jun Yang, et al.
Published: (2016-09-01)

Current Therapeutic Strategies for Glioblastoma
by: Julien Rossignol, et al.
Published: (2019-12-01)

Understanding Glioblastoma Signaling, Heterogeneity, Invasiveness, and Drug Delivery Barriers
by: Nadin Rabah, et al.
Published: (2023-09-01)

Multifunctional exosome-mimetics for targeted anti-glioblastoma therapy by manipulating protein corona
by: Jun-Yong Wu, et al.
Published: (2021-12-01)

Metabolic Abnormalities in Glioblastoma and Metabolic Strategies to Overcome Treatment Resistance
by: Weihua Zhou, et al.
Published: (2019-08-01)

Practice Patterns for Managing Recurrent Glioblastoma Multiforme
by: Jitin Bajaj, et al.
Published: (2024-03-01)

Nanoparticle-Based Treatment in Glioblastoma
by: Diogo Roque, et al.
Published: (2023-08-01)

Modernistic and Emerging Developments of Nanotechnology in Glioblastoma-Targeted Theranostic Applications
by: Buddolla Anantha Lakshmi, et al.
Published: (2022-01-01)

Focused ultrasound-mediated blood-brain barrier opening combined with magnetic targeting cytomembrane based biomimetic microbubbles for glioblastoma therapy
by: Chuanshi He, et al.
Published: (2023-08-01)

Clinically relevant orthotopic xenograft models of patient-derived glioblastoma in zebrafish
by: Xiaolin Ai, et al.
Published: (2022-04-01)

Deciphering the Role of Autophagy in Treatment of Resistance Mechanisms in Glioblastoma
by: Imran Khan, et al.
Published: (2021-01-01)

Recognition of a Novel Gene Signature for Human Glioblastoma
by: Chih-Hao Lu, et al.
Published: (2022-04-01)

The Involvement of Exosomes in Glioblastoma Development, Diagnosis, Prognosis, and Treatment
by: Adrian Bălașa, et al.
Published: (2020-08-01)

Applications of Various Types of Nanomaterials for the Treatment of Neurological Disorders
by: Abdul Waris, et al.
Published: (2022-06-01)

Overcoming the blood–brain barrier for the therapy of malignant brain tumor: current status and prospects of drug delivery approaches
by: Ksenia Mitusova, et al.
Published: (2022-09-01)

Nanoparticles drug-delivery systems and antiangiogenic approaches in the treatment of gliomas
by: Maria Caffo, et al.
Published: (2018-01-01)

Overcoming the Blood–Brain Barrier: Successes and Challenges in Developing Nanoparticle-Mediated Drug Delivery Systems for the Treatment of Brain Tumours
by: Ferraris C, et al.
Published: (2020-04-01)